NOT-AI-25-002: Notice of Early Expiration of "Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes", NOT-AI-21-080

Notice of Early Expiration of "Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes", NOT-AI-21-080

Notice Number:

NOT-AI-25-002

Key Dates

Release Date:

December 3, 2024

Related Announcements

October 19, 2021 - Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes. See NOSI NOT-AI-21-080.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that NOT-AI-21-080, “Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes”, will be expired as of December 3, 2024.

Potential applicants interested in this announcement are encouraged to consider NOT-AI-24-085, “Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes”.

Inquiries

Please direct all inquiries to:

Nasrin Nabavi, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3538
Email: [email protected]